Change - Announcement of Appointment::Appointment of Non-Executive and Non-Independent Director as Audit & Risk Committee Member

Issuer & Securities

Issuer/ Manager
RAFFLES MEDICAL GROUP LTD
Securities
RAFFLES MEDICAL GROUP LTD - SG1CH4000003 - BSL
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
01-Apr-2026 18:01:20
Status
New
Announcement Sub Title
Appointment of Non-Executive and Non-Independent Director as Audit & Risk Committee Member
Announcement Reference
SG260401OTHR9240
Submitted By (Co./ Ind. Name)
Kimmy Goh
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Appointment of Non-Executive and Non-Independent Director as a member of the Audit & Risk Committee.

Additional Details

Date of appointment
25/04/2026
Name of person
Dr Lu Liangjian David
Age
35
Country of principal residence
Singapore
Date of last re-appointment (if applicable)
26/04/2024
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Board has considered the Nomination & Compensation Committee's recommendation and assessment of the qualifications and experience of Dr Lu Liangjian David (Dr Lu) and is satisfied that Dr Lu will contribute relevant knowledge, skills and experience as well as healthcare-related insights to the Audit & Risk Committee.

The Board considers Dr Lu to be non-independent for the purpose of Rule 704(8) of the Listing Manual of the Singapore Exchange Securities Trading Limited.
Whether appointment is executive, and if so, the area of responsibility
Non-Executive
Job title (e.g. Lead ID, AC Chairman, AC Member etc.)
Non-Executive and Non-Independent Director
Professional qualifications
1. Master of Medicine (Paediatric Medicine), National University of Singapore
2. Membership of the Royal College of Paediatrics and Child Health
3. University of Cambridge
- Master of Arts
- MB BChir
- Bachelor of Arts (Honours) (First Class)
Working experience and occupation(s) during the past 10 years
National University Hospital, Singapore, Department of Paediatrics
- Consultant (2025 to Present)
- Associate Consultant (Feb 2023 to Dec 2024)
- Senior Resident (2020 to Feb 2023)
- Resident (Jul 2016 to 2019)
Shareholding interest in the listed issuer and its subsidiaries
Yes
Shareholding details
Deemed Interest : 62,755,366 ordinary shares in Raffles Medical Group Ltd
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Dr Lu is the son of Dr Loo Choon Yong, Executive Chairman of Raffles Medical Group Ltd, and the brother of Dr Sarah Lu Qinghui, Executive and Non-Independent Director of Raffles Medical Group Ltd.
Conflict of interest (including any competing business)
Nil
Undertaking (in the format set out in Appendix 7.7 or Appendix 7H) under Mainboard Rule 720(1) or Catalist Rule 720(1) has been submitted to the listed issuer
Yes
Other Principal Commitments* Including Directorships#
* "Principal Commitments" has the same meaning as defined in the Code of Corporate Governance.
# These fields are not applicable for announcements of appointments pursuant to Mainboard Rule 704(9) or Catalist Rule 704(8).
Past (for the last 5 years)
National University Hospital, Singapore, Department of Paediatrics (Senior Resident, Associate Consultant)
Present
Raffles Medical Group Ltd (Non-Executive and Non-Independent Director)
S & D Holdings Pte Ltd (Director)

Other Principal Commitments:
National University Hospital, Singapore, Department of Paediatrics (Consultant)
Information Required
Disclose the following matters concerning an appointment of director, chief executive officer, chief financial officer, chief operating officer, general manager or other officer of equivalent rank. If the answer to any question is "yes", full details must be given.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of:-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere,
in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Disclosure applicable to the appointment of director only.
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If yes, please provide details of prior experience.
Dr Lu is currently a Non-Executive and Non-Independent Director of the Company since 1 August 2023.